Edit Symbol List
Enter up to 25 symbols separated by commas or spaces in the text box below. These symbols will be available during your session for use on applicable pages.
Don't know the stock symbol? Use the
Symbol Lookup tool.
Alphabetize the sort order of my symbols
Investing just got easier…
Sign up now to become a NASDAQ.com member and begin receiving instant notifications when key events occur that affect the stocks you follow.Access Now X
ETFs with BLUE as a Top 10 Holding*
|Weighting||ETF Name (Symbol)||100-Day Price Change (%)|
|3.34%||ALPS Medical Breakthroughs ETF (SBIO)||+8.64 (32.68%)|
|0.8%||iShares Microcap ETF (IWC)||+5.40 (7.19%)|
Company Description (as filed with the SEC)
We are a clinical-stage biotechnology company committed to developing potentially transformative gene therapies for severe genetic and rare diseases and in the field of T cell-based immunotherapy. With our lentiviral-based gene therapy and gene editing capabilities, we have built an integrated product platform with broad potential application in these areas. Many diseases have a genetic aspect whereby a dysfunctional gene linked to a disease is passed down from generation to generation and causes the disease. For the treatment of severe genetic and rare diseases, gene therapy seeks to introduce a functional copy of the defective gene into a patient's own cells, a process called gene transfer. In this context, we believe that gene therapy has the potential to change the way these patients are treated by correcting the underlying genetic defect that is the cause of their disease, rather than offering solutions that only address their symptoms. ... More ...
Where does BLUE fit in the risk graph?
|Annual EPS Est:||$-1.82|
|Quarterly EPS Est:||-0.87|